CAMV
Concord Asset Management (Virginia)’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,259
| Closed | -$1.33M | – | 203 |
|
|
2025
Q1 | $1.33M | Buy |
2,259
+972
| +76% | +$571K | 0.29% | 77 |
|
|
2024
Q4 | $917K | Buy |
1,287
+223
| +21% | +$159K | 0.2% | 85 |
|
|
2024
Q3 | $1.12M | Buy |
1,064
+152
| +17% | +$160K | 0.25% | 71 |
|
|
2024
Q2 | $959K | Buy |
912
+388
| +74% | +$408K | 0.24% | 80 |
|
|
2024
Q1 | $504K | Buy |
524
+48
| +10% | +$46.2K | 0.13% | 103 |
|
|
2023
Q4 | $418K | Buy |
+476
| New | +$418K | 0.12% | 107 |
|